TG Therapeutics Inc (TGTX) — Cash Flow-to-Debt Ratio
TG Therapeutics Inc (TGTX) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2026, meaning its operating cash flow of $21.37 Million could theoretically repay 0% of its total liabilities ($1.04 Billion) in one year. See TG Therapeutics Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
TG Therapeutics Inc Cash Flow-to-Debt Ratio (1996–2025)
Historical debt coverage capacity for TG Therapeutics Inc across 30 annual periods. For the full cash flow conversion analysis, see TG Therapeutics Inc cash flow conversion.
Annual Cash Flow-to-Debt Ratio for TG Therapeutics Inc (1996–2025)
Year-by-year debt coverage analysis for TG Therapeutics Inc. Check TGTX cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.06x | $-24.77 Million | $415.23 Million | ▲ +47.7% |
| 2024 | -0.11x | $-40.52 Million | $355.33 Million | ▲ +38.6% |
| 2023 | -0.19x | $-31.41 Million | $169.09 Million | ▲ +85.8% |
| 2022 | -1.31x | $-176.17 Million | $134.99 Million | ▲ +37.1% |
| 2021 | -2.07x | $-295.63 Million | $142.48 Million | ▼ -2.8% |
| 2020 | -2.02x | $-214.51 Million | $106.29 Million | ▼ -89.0% |
| 2019 | -1.07x | $-132.81 Million | $124.40 Million | ▲ +50.7% |
| 2018 | -2.16x | $-128.93 Million | $59.58 Million | ▼ -124.7% |
| 2017 | -0.96x | $-93.76 Million | $97.38 Million | ▲ +14.4% |
| 2016 | -1.12x | $-61.59 Million | $54.78 Million | ▼ -185.5% |
| 2015 | -0.39x | $-44.69 Million | $113.47 Million | ▲ +2.6% |
| 2014 | -0.40x | $-35.06 Million | $86.75 Million | ▼ -79.6% |
| 2013 | -0.22x | $-10.82 Million | $48.11 Million | ▲ +71.7% |
| 2012 | -0.80x | $-5.19 Million | $6.52 Million | ▼ -5660.2% |
| 2011 | -0.01x | $-86.58K | $6.27 Million | ▲ +83.2% |
| 2010 | -0.08x | $-1.97 Million | $24.00 Million | ▲ +44.1% |
| 2009 | -0.15x | $-1.05 Million | $7.15 Million | ▲ +81.4% |
| 2008 | -0.79x | $-4.44 Million | $5.62 Million | ▲ +85.5% |
| 2007 | -5.47x | $-10.23 Million | $1.87 Million | ▼ -37.0% |
| 2006 | -3.99x | $-7.75 Million | $1.94 Million | ▼ -6.4% |
| 2005 | -3.75x | $-6.24 Million | $1.67 Million | ▲ +21.2% |
| 2004 | -4.76x | $-5.69 Million | $1.20 Million | ▼ -33.2% |
| 2003 | -3.57x | $-3.45 Million | $966.02K | ▼ -44.1% |
| 2002 | -2.48x | $-1.43 Million | $577.73K | ▲ +71.8% |
| 2001 | -8.80x | $-4.47 Million | $508.61K | ▼ -1487.3% |
| 2000 | -0.55x | $-1.15 Million | $2.08 Million | ▲ +85.5% |
| 1999 | -3.83x | $-2.30 Million | $600.00K | ▲ +11.5% |
| 1998 | -4.33x | $-2.60 Million | $600.00K | ▲ +57.7% |
| 1997 | -10.25x | $-4.10 Million | $400.00K | ▲ +23.1% |
| 1996 | -13.33x | $-4.00 Million | $300.00K | — |